Health

This week, the FDA granted breakthrough device designation to Aurenar‘s V-Link system, a non-invasive nerve stimulation device designed to treat cerebral vasospasm. Vasospasm is one of the most dangerous complications …

Color, a virtual cancer clinic, announced Tuesday that it has expanded its Expert Medical Opinion services to include a new peer-to-peer program. San Francisco-based Color serves employers, health plans, unions …

UnitedHealthcare Group opened its doors to a group of journalists and influencers at its headquarters last month and MedCity News Editor in Chief Arundhati Parmar was among them. On the …

This week, Neurovalens‘ Modius Spero became the first neuromodulation device to earn FDA approval to treat PTSD. Veterans, who face disproportionately high PTSD rates, will be the first to gain …

Many blood cancers can be treated with a potentially curative stem cell transplant, but this procedure introduces a serious complication risk that can become deadly. A new type of cell …

Evernorth, the health services division of The Cigna Group, launched a new AI-powered program for specialty pharmacy on Thursday called Pharmacy Forward. The program is backed by a $100 million …

Welcome back to another episode of MedCity FemFwd, a podcast dedicated to exploring the breakthroughs and challenges in women’s health. In this episode, we’re joined by Dr. Cathleen Brown, medical …

It’s been a busy few months for Servier, which followed its $2.5 billion acquisition of cancer biotech Day One Biopharmaceuticals with a $1.5 billion agreement to buy the neuromuscular business …

Anthropic is rolling out Claude Science, an AI workbench for pharma researchers. The buzzy AI startup says this new product goes beyond assisting scientists to actually doing their work.  “Claude …